Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
In brief, in English
This call supports the development of monoclonal antibodies to prevent and treat Flavivirus infections under the Horizon Europe programme. Detailed eligibility criteria regarding who can apply are not specified in the text.
Written by a model from the publisher's text. The official page is the authority. How data is produced
Program: Horizont Evropa
Termín pro podání žádosti: 29. 10. 2026 - 17. 2. 2027
Program EU
Historia zmian
First seen 09 Nov 2026, last checked 22 Nov 2026. 1 recorded version.
- 09 Nov 2026 · 1d4f34563ac1